Longevity has evolved into the buzzword of the health space. It’s also imprecise to the point of meaningless.
The traditional David Sinclair-sponsored camp now runs on the premise aging is a disease that is both treatable and reversible. A single, giant problem waiting on a single, giant solution.
Our view is quite the contrary: build resilient health infrastructure by its components (i.e. organs & bodily systems). Fix what’s broken & improve systems in a targeted way. As opposed to throwing sh*t at the proverbial longevity wall.
Any intervention worth implementing answers “yes” to all three:
Is it specific? → What problem is this solving?
Is it measurable? → Is a biomarker, a behavior, or a feeling moving over time?
Is it practical? → Can you do it continually without a longevity clinic, a six-figure protocol, or a neurotic 47-step morning routine?
The industry falls short on all three.
Now for a proper rundown on all the longevity psyops I’m not falling for.
Resveratrol
The Hype
The king of overhyped supplements & notorious “red wine” polyphenol (you’ll get more from a handful of grapes & blueberries anyways). Claims are to mimic caloric restriction & of course extend lifespan.
David Sinclair’s lab rode the longevity wave from cell line studies → mice → his company, Sirtris, that GlaxoSmithKline bought for $720 million.
Why It’s Overhyped
“The story of resveratrol turns out to be another case where you get a lot of hype about health benefits that doesn’t stand the test of time.”
– Dr. Richard D. Semba (lead author of 2014 resveratrol study in JAMA Internal Medicine)
150+ human trials showing either neutral or in some cases even negative effects like blunting the benefits of exercise.
Pick your flavor of failed test, you can bet it’s here:
No lifespan effects in longevity models: No lifespan extension at any dose. Sinclair was a co-author.
No cardiometabolic impacts on the longest human RCT: 6-month trial. 41 adults randomized to 150 mg/day or placebo. No differences in insulin sensitivity, liver fat, body composition, blood pressure, energy metabolism, or physical performance.
No mortality reduction link for humans: 783 adults tracked for 9 yrs. Urinary resveratrol levels had no association to inflammatory markers, cardiovascular disease, cancer, or all-cause mortality.
Brain volume loss experienced: 52-week Alzheimer’s trial at up to 2 g/d. Greater brain volume loss in the resveratrol group than placebo.
GSK’s self own: Reached the same conclusion with its own money. Their proprietary blend (SRT501) was abandoned in 2010 over poor tolerability & adverse renal outcomes. Sirtris was shut down in 2013.
Highly estrogenic: Hormonally disruptive. Increases sex hormone binding globulin. Lowers free testosterone. Raises estrogenic activity.
Biological Age Tests (Epigenetic Clocks & Telomere Length)
The Hype
Direct-to-consumer tests that output a single value as your “biological age”. TruDiagnostic, Elysium, Generation Lab, & Sinclair’s Tally Health all sell subscription versions.
Why It’s Overhyped
“I don’t recommend that people get them unless you just want it for entertainment value”
— Dr. Matt Kaeberlein (Founding Director of the UW Healthy Aging & Longevity Research Institute)
The biological age gamification model:
Get a baseline biological “age”.
Provide you the “solutions” to lower your “age”.
Re-measure your “age”.
Run the loop all over again.
They leverage a human flaw: our bias to create neat & compressed models (stories) for the intimidating complexities of human life.
Unfortunately, they don’t serve as useful on the individual level (at least not yet):
Same sample with different “ages”: When identical samples are split by testing method, there were deviations up to 9 years.
Cheek swab ≠ blood draw: Oral swabs (preferred by leading companies) vs. blood estimates differed by ~30 years in some clocks across 284 samples.
Good for population analysis. Poor for individual clinical use: “there are substantial technological & biological barriers that prohibit current epigenetic clocks from being useful on an individual level…epigenetic clocks at an individual level may lead to harmful societal and personal consequences.”
The inventor built it for labs:
Cost-efficient + comprehensive blood biomarkers >> biological age tests
If you’re reading this, you probably care about your long-term health like me. That’s why I ignore the random number generator tests and opt for hundreds of proven biomarkers at a fraction of the biological age test cost.
That’s also why I’ve been using Superpower for the last 2 years and haven’t looked back.
No one will ever care about your own health more than you. And Superpower is the path to taking your health into your own hands.
100+ biomarkers tracked longitudinally
3,000+ labs nationwide for convenient testing
24/7 unlimited access to medical practitioners
All for less than $15/month.
Test. Don’t guess.
Blue Zones
The Hype
Five regions identified in the early 2000s as having unusually high concentrations of people living past 100:
Ikaria, Greece
Sardinia, Italy
Okinawa, Japan
Nicoya, Costa Rica
Loma Linda, California
Belgian demographer Michel Poulain & Italian physician Giovanni Pes teamed up to publish the AKEA study in 2004. Journalist Dan Buettner later joined the project, published a National Geographic cover story, & trademarked the term the following year.
The premise was simple: Find where people live longest. Identify their habits. Copy the protocol.
Pop culture took it & ran. Nine bestselling books, one 2023 Netflix documentary, and one consulting business that certifies “blue zone” cities later.
Why It’s Overhyped
“The secret to extreme longevity is to move where birth certificates are rare, teach your kids pension fraud & start lying.”
— Saul Newman (Ig Nobel acceptance speech)
Buettner sold Blue Zones LLC to Adventist Health in 2020 for $78 million.
Cities now pay $100k/year to keep the designation.
A five-year contract with an Iowa insurer covering 10+ cities cost an ~$25 million.
Frozen blue zone meals are now in 4,000+ grocery stores across the US.
All of the hype built on a foundation of fraudulent centenarian stats:
Only 18% of validated centenarians have a birth certificate: When you bring actual birth certificates into the mix, there’s a 69–82% drop in centenarian records in these regions. Ironically, the strongest predictors of 100+ years of age were high poverty, missing birth certificates, fewer 90+ year old people, & high crime rates.
When Japan conducted an audit, 82% were dead: A Japanese gov’t review found 82% of their 100+ population was long deceased. Many killed in World War II then kept alive on paper to collect the pension.
Japan isn’t alone: In Greece, 72% of centenarians were dead or made up people. In Costa Rica, 42% lied about their age.
Loma Linda was added to appease Nat Geo editors: Buettner admitted including the California site only because National Geographic asked for a U.S. location. Poulain never acknowledged it as a blue zone.
Rapamycin
The Hype
FDA-approved immunosuppressant isolated from soil bacteria on Easter Island. Used since 1999 to prevent organ transplant rejection.
Rapamycin has the strongest result the NIA Interventions Testing Program ever produced. It increased median lifespan 23% in male mice & 26% in females with max lifespan up for both.
BUT…(and it’s a big one).
Why It’s Overhyped
Rapamycin is a case of *potentially* improving lifespan at an exceptionally steep cost of degrading healthspan.
The untold rapamycin story you won’t hear in most longevity circles is one of its awful side effects:
Flagship human trial fell short: 48-week trial of 114 adults taking 5 or 10 mg weekly. Nearly all primary outcomes weren’t impacted: visceral fat, bone density, epigenetic age, gut microbiome, & every blood biomarker (CBC, electrolytes, liver, kidney, glucose, insulin, HbA1c). Every author is an employee & shareholder of AgelessRx…which sells rapamycin.
Mice die of cancer: Rapamycin prevents abnormal cells from dividing & spreading. UM-HET3 mice used in these “longevity” trials often die of tumors so a disproportionately high share of the lifespan gain is cancer suppression in a highly cancer-prone animal. NOT a deceleration of aging.
Side effects:
“Rapamycin is really bad for your thymus…kills your thymus. It blocks T cell maturation in the cortex of the thymus…and that’s at doses equivalent to the therapeutic doses people are using.” (Dr. Greg Fahy)
Forms cataracts (in mice)
Bryan called it quits: Bryan Johnson took rapamycin for ~5 years across weekly (5, 6, 10 mg) & biweekly (13 mg) protocols. He stopped in September 2024 citing skin infections, lipid issues, poor glucose metabolism, & elevated resting heart rate: “the benefits of lifelong dosing of rapamycin do not justify the hefty side-effects.”
Metformin
The Hype
An oral antidiabetic medication derived from French lilac that’s been in use since the 1950s.
Its longevity appeal is based on a single observation where a sick population outlived a relatively healthy one. This 2014 study of 78k type 2 diabetics on metformin found they had lower all-cause mortality than matched non-diabetic controls.
Why It’s Overhyped
“There is a lack of support for metformin extending healthspan in human subjects.”
— Konopka & Miller, GeroScience (2019)
We still have neither efficacy data nor a randomized trial that has ever tested metformin for aging in metabolically healthy people.
But we do have enough to refute its longevity benefit:
ITP tested it with no benefit: No increase in median or maximum lifespan in either male or female mouse models.
OG study inverted: 2014 result that put metformin on the longevity map found that diabetics on it outlived healthy non-diabetics. Data from Danish national registers showed metformin users died FASTER at every level of use & every cumulative dose.
21 years of the foundations beat Big Pharma: 1,173 participants tracked via Medicare claims. Metformin group at 1,700 mg daily had no statistically significant reduction vs. placebo. The lifestyle (nutrition + training) group had 21% LOWER risk of two chronic conditions & 25% LOWER risk of three.
Steep cost of side effects:
Blunts aerobic adaptation: Adjacent to 12 weeks of cardio training in older adults, metformin reduced the increase in insulin sensitivity & cut the cardio aerobic fitness by half.
Blunts hypertrophy: 14 weeks of resistance training for 65+ yr olds adults dosed at 1,700 mg/day. Placebo gained MORE lean body mass (p=.003) & MORE thigh muscle mass (p<.001) than metformin.
Thymic involution: Metformin tricks the thymus into thinking it’s starving. Developing T cells get tagged for survival, then killed anyway so it ends up shrinking.
Spermidine
The Hype
Naturally occurring compound that induces autophagy. Richest in wheat germ, aged cheeses, & veggies (broccoli, mushrooms).
Gained attention via two big findings:
2016 paper showing lifespan extension in mice
2018 prospective cohort of 800+ Italians showing spermidine levels inversely associated with mortality
Why It’s Overhyped
“Spermidine did not modify memory and biomarkers compared with placebo.”
— the SmartAge investigators on their own 12-month trial
Zero human trials with a lifespan or mortality outcome.
The problems unveiled within one yearlong RCT in 100 people, a food questionnaire, & mice model testing:
S-tier human trial failed: 100 adults 60–90 yrs old with cognitive decline had no significant change across 6 cognitive measurements & 21 other biomarkers. Co-author Frank Madeo also sells spermidine.
Mortality data is grocery questionnaire-based: The most robust observational data. Spermidine intake also tracks with a micronutrient-dense, whole food diet high in both fruits & vegetables. A major confounder.
Authors of “evidence” = leaders at spermidine biz The Longevity Labs:
Frank Madeo – Senior author on the entire evidence base (6 major papers). Has equity & serves as advisor at spermidineLIFE (The Longevity Labs).
Tobias Eisenberg – First author on 2 major papers. Has equity & serves as advisor at The Longevity Labs. Holds patents on use of spermidine.
Slaven Stekovic – Co-author on 2 major papers. CEO of The Longevity Labs.
HBOT
The Hype
Breathing 100% pure oxygen inside a chamber pressurized above sea level for 60–90 min/session.
The longevity claim is based on a 2020 clinical trial at Israel’s Sagol Center. 60 daily sessions in adults over 64: telomere length in immune cells (T helper, cytotoxic T, natural killer, & B) rose by ~ 20%.
Results fueled the birth of Aviv Clinics who’ve raised $75 million and sell a three-month program starting at ~$30k.
Why It’s Overhyped
Case of a significant confounding factor in the longevity space: people age well because they’re able to use the chamber without stressing, not because of the chamber’s mechanism itself. The healthy & wealthy user bias.
14 approved use cases, but aging isn’t one of them:
Potential for worsening mitochondrial damage: AVOID if you’re not metabolically dialed in. HBOT hits mitochondria hard as a form of stress flooding tissues with oxygen & inducing oxidative stress. If the baseline for a user is metabolically weak, it’s dumping fuel to an already burning fire.
Founding study was uncontrolled: 35 healthy adults all got HBOT. But there was no placebo, sham, or any comparison arm. Every author has ties to the Sagol Center.
Cognitive “RCT” wasn’t blinded: Everyone in the trial knew which group they sat in. The control group was non-intervention rather than sham-intervention.
Once HBOT was finally blinded…the sham won: 155 older adults were randomized double-blind to HBOT or sham. Cognitive function significantly favored sham. HBOT group had more serious adverse events.
AKG (Ca-AKG/Rejuvant)
The Hype
Sold as calcium alpha-ketoglutarate. Most popularly as Rejuvant → a timed-release Ca-AKG plus vitamin A for men & vitamin D for women.
Two results serve as the backbone for AKG:
In 2020, Ca-AKG started at 18 months of age extended median lifespan in female mice and cut frailty scores 46% in females & 41% in males.
Then in 2021, 42 people taking Rejuvant for an average of seven months showed a roughly 8-year reduction in biological age on a DNA methylation test.
Why It’s Overhyped
No randomized controlled trial in humans to date.
Evidence in favor is sparse, but debunking fuel is plenty:
Two tests. Two fails.: One starting at 18 months and the other starting at 7 months in the mouse model. Neither start age produced any longevity benefit in either sex. Brian Kennedy sits on the board of the company that sells Rejuvant & was also a co-author on this paper.
OG result = one strain, one lab, females only: Female mice saw some lifespan improvement, but males had no life gain. Four of the authors are shareholders of Ponce de Leon Health, the biz behind Rejuvant.
“8 years younger” paper = customer reviews: The 8-year biological age reduction study that headlines the product came from 42 people who bought the supplement themselves without a control group, placebo, or randomization. Called it “a randomized retrospective study”....which is not actually a thing.
Oral AKG’s poor bioavailability: Half-life <5 minutes. ~40% is absorbed and metabolized by the intestinal mucosa.
LifeWave Phototherapy Patches
The Hype
An adhesive, non-transdermal patch worn on the skin sold by a multi-level marketing firm.
Claimed mechanism is stem cell activation via phototherapy. They’re designed “to trap infrared energy…which causes them to reflect it back to stimulate specific points on the skin that can promote a general state of health.”
Why It’s Overhyped
“I found there was no strong reason to think the patches would activate stem cells or do so in a meaningful way to have systemic positive effects. A little patch also only exposes a correspondingly small area of skin.”
— Paul Knoepfler, PhD, stem cell biologist at UC Davis
The rest:
A doctor ended up in the ER: In 2023, a 37 yr old family medicine physician tried X39 for ankle pain. Second patch resulted in sudden severe migraine and an ER visit.
Zero supportive data: Independent trials found little. 1 of 8 endurance/power gain measurements improved vs. placebo for college football players. No performance benefit in cross-country runners.
TA-65
The Hype
Telomerase activator that flips telomerase back on to rebuild the repetitive DNA caps on chromosomes & slow biological aging.
TA-65 is the commercial version sold by Telomerase Activation Sciences and extracted from Astragalus membranaceus.
Why It’s Overhyped
“Dietary supplementation of TA-65 has no effect on lifespan in female mice.”
— Bernardes de Jesus et al., Aging Cell, 2011 (research paper the industry cites as its proof)
Three human studies. All of which have authors who consult for, work at, or sell the product:
Main mouse study found no lifespan extension: No benefits in lifespan. Calvin Harley is a TA Sciences consultant & co-author.
Customer-based human study: The 2011 paper analyzed paying customers taking TA-65, a supplement pack, & physician counseling. There was no control group, placebo, or randomization.
Single real RCT = inverted dose-response: Across 117 older adults, 12 months of the low dose (250 U) added 530 bp of telomere length, but the high dose (1000 U) failed. 5 of 6 authors consult/work directly for T.A. Sciences.
FTC claims’ crackdown: It wouldn’t be a true longevity company if they didn’t earn their FTC stripes with “reverse aging” claims. Par the course.
Oral NR/NMN
The Hype
NAD⁺ is a coenzyme in every cell. Needed for the reactions that convert food into usable energy. Levels decline with age.
NAD⁺ itself gets broken down in the gut before absorption. So the longevity market turns to the two primary precursors: nicotinamide mononucleotide (NMN) & nicotinamide riboside (NR) → vitamin B3 derivatives.
Why It’s Overhyped
“I’m telling you that nicotinamide riboside is not a longevity drug.”
— Charles Brenner, PhD, who discovered NR’s role as an NAD⁺ precursor & serves as Chief Scientific Advisor to the company that sells it
Neither NR nor NMN have extended lifespan in a mammal under controlled conditions:
No longevity impact from NR: Mice fed NR for an 8-month period showed no lifespan effect in either sex.
No mitochondrial effects in human trials: NR tested at 1 g/day NR for 21 days increased muscle NAD⁺ metabolome up, but had no impact on mitochondrial function or cardiometabolic markers. 12 weeks of NR @ 2g/day had no effect on insulin sensitivity, resting energy expenditure, fat-burning potential, lipid oxidation, or body composition.
Flagship NMN trial failed twice: 10 weeks of NMN @ 250 mg increased muscle insulin sensitivity by 25%. But no detectable change in muscle NAD⁺, mitochondrial oxidative capacity, body composition, liver, or adipose markers.
The 11 Psyops Recapped:
Resveratrol
Aging biomarker tests (bio-age clocks + telomere length)
Blue Zones
Rapamycin
Metformin
Spermidine
HBOT
Telomerase activators (TA-65)
Alpha-ketoglutarate (Ca-AKG / Rejuvant)
LifeWave X39 patches
NMN & NR (oral NAD⁺)
Stay vigilant out there.
Your friend,
Phys
I love it! Thanks man, i am grateful that men like you exists, you expose psyops without selling a thing. God bless you
I would like to pick your brain on urolithin A. Some claim benefits after long term use (4 months).